Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 696215
                    [Title] => Synovate launches hyperlipidaemia monitor in AsPac
                    [Summary] => 
Synovate Healthcare, the health care specialist unit of global market research firm Synovate, announced that it has launched its newest syndicated therapy monitor focusing on the drug treatment of patients with hyperlipidaemia in the Asia-Pacific.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

HYPERLIPIDAEMIA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 696215
                    [Title] => Synovate launches hyperlipidaemia monitor in AsPac
                    [Summary] => 
Synovate Healthcare, the health care specialist unit of global market research firm Synovate, announced that it has launched its newest syndicated therapy monitor focusing on the drug treatment of patients with hyperlipidaemia in the Asia-Pacific.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Synovate launches hyperlipidaemia monitor in AsPac

June 16, 2011 - 12:00am

Synovate Healthcare, the health care specialist unit of global market research firm Synovate, announced that it has launched its newest syndicated therapy monitor focusing on the drug treatment of patients with hyperlipidaemia...

Science and Environment